$25.62
-0.33 (-1.27%)
Market Cap
$1.3B
Shares Outstanding
49,708,656
Institutional Holders
67
Total Inst. Value
$464.4M
% of Float Held
301.7%
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | TRV GP IV, LLC | $66.9M | 6,073,958 |
| 2 | Frazier Life Sciences Management, L.P. | $45.5M | 4,129,001 |
| 3 | ARCH Venture Management, LLC | $45.4M | 4,120,053 |
| 4 | Octagon Capital Advisors LP | $42.5M | 2,341,667 |
| 5 | Deep Track Capital, LP | $36.0M | 3,269,126 |
| 6 | Matrix Capital Management Company, LP | $27.4M | 2,486,184 |
| 7 | Alphabet Inc. | $26.6M | 2,412,471 |
| 8 | Foresite Capital Management IV, LLC | $23.3M | 2,111,919 |
| 9 | a16z Capital Management, L.L.C. | $18.7M | 1,702,225 |
| 10 | General Catalyst Group Management, LLC | $11.4M | 1,035,910 |
Related Stocks
Frequently Asked Questions
How many institutional investors hold MAZE?
As of Q1 2025, 67 institutional investors report holding MAZE (Maze Therapeutics, Inc.) in their 13F filings.
What percentage of Maze Therapeutics, Inc. is owned by institutions?
Institutional investors hold approximately 301.7% of Maze Therapeutics, Inc.'s float as reported in SEC 13F filings.
Which hedge fund owns the most MAZE?
The largest institutional holder of MAZE is TRV GP IV, LLC with $66.9M in shares.
Are institutions buying or selling MAZE?
This quarter, 67 institutions opened new positions in MAZE and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.